Skip to main content

Prognostic value of trisomy 8 in primary myelodysplastic syndrome

Buy Article:

$43.00 plus tax (Refund Policy)

Background:  According to the International Prognostic Scoring System (IPSS), sole +8 is categorized as intermediate cytogenetic subgroup. But as some myelodysplastic syndrome (MDS) patients with +8 perhaps progress quickly to acute leukaemia and have shorter survival, some reports have suggested that +8 should be categorized into poor risk cytogenetic group. The aim of this study was to clarify the prognostic role of +8 in MDS patients by comparing patients with normal karyotype, 20q‐ and ‐7/7q‐.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: cytogenetics; myelodysplastic syndrome; prognosis

Document Type: Research Article

Affiliations: Department of Hematology, Huashan Hospital, Fudan University, Shanghai, China

Publication date: 2010-10-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more